Metabolism-resistant bradykinin antagonists: Development and applications

Biological Chemistry

Volumn 382, Issue 1, 2001, Pages 37-42

  Stewart, J M ^a   Gera, L ^a   York, E J ^a   Chan, D C ^a   Whalley, E J ^a   Bunn P A , Jr ^a   Vavrek, R J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Enzyme hydrolysis; Inflammation; Receptors, B1; Receptors, B2

Indexed keywords

B 10054; B 10206; B 10238; B 9430; B 9870; B 9872; B 9958; BRADYKININ ANTAGONIST; DELTIBANT; DEXTRO ARGINYLBRADYKININ[3 HYDROXYPROLINE 5,8 [3 (2 THIENYL)ALANINE] 7 DEXTRO PHENYLALANINE]; ICATIBANT; LYSYLLYSYLARGINYLPROLYL(4 HYDROXYPROLYL)GLYCYL 2 (2,3 DIHYDRO 1H INDEN 2 YL)GLYCYLSERYL 2 (2,3 DIHYDRO 1H INDEN 2 YL)GLYCYLOCTAHYDRO 1H INDOLE 2 CARBOXYLIC ACID; M 226; M 294; M 516; M 570; M 622; UNCLASSIFIED DRUG;

ANIMAL TISSUE; CANCER; CONTROLLED STUDY; DRUG METABOLISM; DRUG POTENCY; DRUG RESISTANCE; ENZYME DEGRADATION; GUINEA PIG; HORMONE SYNTHESIS; INFLAMMATION; INJURY; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; BIOLOGICAL ASSAY; HUMANS; KININS; PEPTIDES; RECEPTORS, CELL SURFACE; SPECIES SPECIFICITY;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0035112694     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2001.006     Document Type: Review

References (30)

1. 2 kinin receptor antagonist, of antigen-induced nasal blockage
2. Neuropeptide signal transduction in lung cancer: Clinical implications of bradykinin sensitivity and overall heterogeneity
3. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines
4. Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia
5. Novel bradykinin antagonist dimers for the treatment of human lung cancers
6. A new class of bradykinin antagonists: Synthesis and in vitro activity of bissuccinimidoalkane peptide dimers
7. Some old and some new ideas on kinin metabolism
8. Novel highly-potent bradykinin antagonists containing pentafluorophenylalanine
9. 1 receptors
10. Dimers of bradykinin antagonists and their smaller molecular mimetics as potential anti-cancer drugs
11. Kinin B1 receptor antagonists containing alpha-methyl-L-phenylalanine. In vitro and in vivo antagonistic activities
12. HOE-140, a new, potent and long acting bradykinin antagonist: In vitro studies
13. Small molecule antagonists of the bradykinin B1 receptor
14. Characterization of FR173657, a novel, non-peptide BK2 antagonist, in vitro and in vivo
15. The codependence of angiogenesis and chronic inflammation
16. (D-Arg1, D-Phe5, D-Trp7,9, Leu11)Substance P acts as a biased agonist toward neuropeptide and chemokine receptors
17. Bradykinin and nitric oxide in infectious disease and cancer
18. 1 receptors for kinins
19. B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects
20. Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin receptor antagonist
21. The kallikrein/kinin system and kinin antagonsists in trauma
22. Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor
23. Inactivation of bradykinin in the pulmonary circulation
24. A new generation of bradykinin antagonists
25. Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications
26. Potent, wide-spectrum, orally-active bradykinin antagonists
27. Bradykinin antagonists: Present progress and future prospects
28. Competitive antagonists of bradykinin
29. Development and modification of competitive antagonists of bradykinin
30. Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger